SCHEMBL7985304

SCHEMBL7985304

Oc1nc(C2CCCC2)nc2ncn(Cc3ccccc3)c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.44
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 1/20 0.41
HPGD P15428 1/20 0.40
CYP19A1 P11511 1/20 0.37
GAA P10253 2/20 0.37
CTSL P07711 1/20 0.37
CTSB P07858 1/20 0.37
PARN O95453 1/20 0.37
CNOT7 Q9UIV1 1/20 0.37
PDE5A O76074 1/20 0.37
TNF P01375 1/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985354 0.99 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1KMT2AHPGDCYP19A1
SCHEMBL7974103 0.81 SMN1; SMN2 (0.42) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7974024 0.77 HPGD (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7975267 0.76 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7975252 0.74 HPGD (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7988099 0.74 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7985343 0.74 GAA (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7985301 0.74 KMT2A (0.57) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL7985404 0.73 HPGD (0.49) SMN1; SMN2ALDH1A1KMT2AHPGDGAA
SCHEMBL5464971 0.73 PDE4A (0.52) SMN1; SMN2ALDH1A1KMT2AHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed